Summary
AddiFab has developed the first sacrificial thermoplastic injection moulding platform to support the manufacturing of small/medium size, complex and traceable metal and ceramic components with high precison – STIM-MC. AddiFab’s innovative solution is the first to remove the costly and time-consuming gap between prototyping and commercialization ramp-up. This is only possible due to AddiFab’s proprietary resin and process which uses dissolvable resins to create 3D-printed objects that may be used as injection moulds. It runs in a single platform which integrates the automatic production and postprocessing of moulds. With single-use moulds produced automatically, prototypes and components with mould-like quality can be launched for in-market validation and easily modified. Thus, the STIM-MC platform reduces the product development time and cost, while enabling wider benefits for the healthcare, consumer products and automobile industry through new cost-effective materials. Through the successful development and implementation of the STIM-MC project, AddiFab will be in a strong position to exploit the metal and ceramic injection moulding market, forecasted to reach $5.7 billion by 2022. We expected an acumulated revenue of €167 million, 5 years after project completion.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/849119 |
| Start date: | 01-01-2019 |
| End date: | 30-09-2020 |
| Total budget - Public funding: | 2 298 287,50 Euro - 1 608 801,00 Euro |
Cordis data
Original description
AddiFab has developed the first sacrificial thermoplastic injection moulding platform to support the manufacturing of small/medium size, complex and traceable metal and ceramic components with high precison – STIM-MC. AddiFab’s innovative solution is the first to remove the costly and time-consuming gap between prototyping and commercialization ramp-up. This is only possible due to AddiFab’s proprietary resin and process which uses dissolvable resins to create 3D-printed objects that may be used as injection moulds. It runs in a single platform which integrates the automatic production and postprocessing of moulds. With single-use moulds produced automatically, prototypes and components with mould-like quality can be launched for in-market validation and easily modified. Thus, the STIM-MC platform reduces the product development time and cost, while enabling wider benefits for the healthcare, consumer products and automobile industry through new cost-effective materials. Through the successful development and implementation of the STIM-MC project, AddiFab will be in a strong position to exploit the metal and ceramic injection moulding market, forecasted to reach $5.7 billion by 2022. We expected an acumulated revenue of €167 million, 5 years after project completion.Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
